US0905722072 - BIO - 865406 (XNYS)
BIO-RAD LABS INC Acción
327,47 USD
Cotizaciones actuales de BIO-RAD LABS INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NYSE |
BIO
|
USD
|
20.12.2024 22:03
|
327,47 USD
| 325,94 USD | 0,47 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -4,49 % | -1,67 % | -0,77 % | 13,71 % | 2,10 % | -12,15 % |
Company Profile for BIO-RAD LABS INC Share
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Invested Funds
The following funds have invested in: BIO-RAD LABS INC invested:
Fund | Vol. in million 560,03 | Percentage (%) 1,00 % |
Fund | Vol. in million 6,19 | Percentage (%) 0,46 % |
Fund | Vol. in million 21,04 | Percentage (%) 0,31 % |
Fund | Vol. in million 475,61 | Percentage (%) 0,28 % |
Fund | Vol. in million 857,38 | Percentage (%) 0,24 % |
Company Data for BIO-RAD LABS INC Share
Name BIO-RAD LABS INC
Company Bio-Rad Laboratories, Inc.
Symbol BIO
Website https://www.bio-rad.com
Primary Exchange
NYSE
WKN 865406
ISIN US0905722072
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Mr. Norman D. Schwartz
Market Capitalization 9 Mrd.
Country United States of America
Currency USD
Employees 7,7 T
Address 1000 Alfred Nobel Drive, 94547 Hercules
IPO Date 1980-02-27
Stock Splits
Date | Split |
---|---|
08.03.2002 | 2:1 |
03.06.1996 | 3:2 |
11.06.1986 | 3:2 |
10.06.1986 | 1:1 |
01.08.1985 | 3:2 |
31.07.1985 | 1:1 |
18.03.1980 | 2:1 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | BUWA.F |
NYSE | BIO |
More Shares
Investors who BIO-RAD LABS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.